Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2021-2027

Q: Who are the key players in the breast cancer diagnostic and drug technologies market?

Some of the key players are Abbott, Roche, Biomerieux, Becton Dickinson, GE Healthcare, Hologic Inc, Philips, PerkinElmer Inc, Quest Diagnostics, China, India, Others.

Code: QYRE-Auto-0Y3110

Report

July 2021

Pages:96

QYResearch

Description

Table of Content

Tables & Figures

FEATURED COMPANIES

Breast Cancer Diagnostic and Drug Technologies Market

The global Breast Cancer Diagnostic and Drug Technologies market size is projected to reach USD 19060 Million by 2027, from USD 16050 Million in 2020, at a CAGR of 2.0% during 2021-2027.

Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Diagnostic and Drug Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Diagnostic and Drug Technologies market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Diagnostic and Drug Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Diagnostic and Drug Technologies market.

Breast Cancer Diagnostic and Drug Technologies market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Diagnostic and Drug Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

By Type

Mammography
Biopsy
Other

By Application

Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer

By Region

North America
US.
Canada
Europe
Germany
France
UK.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Companies

Abbott
Roche
BioMerieux
Becton Dickinson
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics

FEATURED COMPANIES

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type: 2016 VS 2021 VS 2027

1.2.2 Mammography

1.2.3 Biopsy

1.2.4 Other

1.3 Market by Application

1.3.1 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application: 2016 VS 2021 VS 2027

1.3.2 Ductal Carcinoma of Breast

1.3.3 Invasive Ductal Carcinoma

1.3.4 Lobular Carcinoma

1.3.5 Triple Negative Breast Cancer

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Perspective (2016-2027)

2.2 Breast Cancer Diagnostic and Drug Technologies Growth Trends by Regions

2.2.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Regions: 2016 VS 2021 VS 2027

2.2.2 Breast Cancer Diagnostic and Drug Technologies Historic Market Share by Regions (2016-2021)

2.2.3 Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Regions (2022-2027)

2.3 Breast Cancer Diagnostic and Drug Technologies Industry Dynamic

2.3.1 Breast Cancer Diagnostic and Drug Technologies Market Trends

2.3.2 Breast Cancer Diagnostic and Drug Technologies Market Drivers

2.3.3 Breast Cancer Diagnostic and Drug Technologies Market Challenges

2.3.4 Breast Cancer Diagnostic and Drug Technologies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue

3.1.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue (2016-2021)

3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Players (2016-2021)

3.2 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Players Covered: Ranking by Breast Cancer Diagnostic and Drug Technologies Revenue

3.4 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio

3.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Diagnostic and Drug Technologies Revenue in 2020

3.5 Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Area Served

3.6 Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service

3.7 Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Type

4.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Type (2016-2021)

4.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2022-2027)

5 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Application

5.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Application (2016-2021)

5.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2022-2027)

6 North America

6.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)

6.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type

6.2.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)

6.2.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)

6.2.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)

6.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application

6.3.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)

6.3.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)

6.3.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)

6.4 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country

6.4.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021)

6.4.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)

7.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type

7.2.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)

7.2.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)

7.2.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)

7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application

7.3.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)

7.3.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)

7.3.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)

7.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country

7.4.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021)

7.4.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic

8 Asia-Pacific

8.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)

8.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type

8.2.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)

8.2.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)

8.2.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)

8.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application

8.3.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)

8.3.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)

8.3.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)

8.4 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region

8.4.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2016-2021)

8.4.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2022-2027)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)

9.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type

9.2.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)

9.2.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)

9.2.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)

9.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application

9.3.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)

9.3.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)

9.3.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)

9.4 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country

9.4.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021)

9.4.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size (2016-2027)

10.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type

10.2.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021)

10.2.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027)

10.2.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2027)

10.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application

10.3.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021)

10.3.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027)

10.3.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2027)

10.4 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country

10.4.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021)

10.4.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Introduction

11.1.4 Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.1.5 Abbott Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Introduction

11.2.4 Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.2.5 Roche Recent Development

11.3 BioMerieux

11.3.1 BioMerieux Company Details

11.3.2 BioMerieux Business Overview

11.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Introduction

11.3.4 BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.3.5 BioMerieux Recent Development

11.4 Becton Dickinson

11.4.1 Becton Dickinson Company Details

11.4.2 Becton Dickinson Business Overview

11.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Introduction

11.4.4 Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.4.5 Becton Dickinson Recent Development

11.5 GE Healthcare

11.5.1 GE Healthcare Company Details

11.5.2 GE Healthcare Business Overview

11.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Introduction

11.5.4 GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.5.5 GE Healthcare Recent Development

11.6 Hologic

11.6.1 Hologic Company Details

11.6.2 Hologic Business Overview

11.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Introduction

11.6.4 Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.6.5 Hologic Recent Development

11.7 Philips

11.7.1 Philips Company Details

11.7.2 Philips Business Overview

11.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Introduction

11.7.4 Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.7.5 Philips Recent Development

11.8 PerkinElmer

11.8.1 PerkinElmer Company Details

11.8.2 PerkinElmer Business Overview

11.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Introduction

11.8.4 PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.8.5 PerkinElmer Recent Development

11.9 Quest Diagnostics

11.9.1 Quest Diagnostics Company Details

11.9.2 Quest Diagnostics Business Overview

11.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Introduction

11.9.4 Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

11.9.5 Quest Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027

Table 2. Key Players of Mammography

Table 3. Key Players of Biopsy

Table 4. Key Players of Other

Table 5. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027

Table 6. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Table 7. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions (2016-2021) & (US$ Million)

Table 8. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2016-2021)

Table 9. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Regions (2022-2027) & (US$ Million)

Table 10. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2022-2027)

Table 11. Breast Cancer Diagnostic and Drug Technologies Market Trends

Table 12. Breast Cancer Diagnostic and Drug Technologies Market Drivers

Table 13. Breast Cancer Diagnostic and Drug Technologies Market Challenges

Table 14. Breast Cancer Diagnostic and Drug Technologies Market Restraints

Table 15. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Players (2016-2021) & (US$ Million)

Table 16. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Players (2016-2021)

Table 17. Global Top Breast Cancer Diagnostic and Drug Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2020)

Table 18. Ranking of Global Top Breast Cancer Diagnostic and Drug Technologies Companies by Revenue (US$ Million) in 2020

Table 19. Global 5 Largest Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue (CR5 and HHI) & (2016-2021)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service

Table 22. Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)

Table 25. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2016-2021)

Table 26. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 27. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2022-2027) & (US$ Million)

Table 28. Global Breast Cancer Diagnostic and Drug Technologies Market Size Share by Application (2016-2021) & (US$ Million)

Table 29. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Application (2016-2021)

Table 30. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 31. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Application (2022-2027) & (US$ Million)

Table 32. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)

Table 33. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)

Table 34. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)

Table 35. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)

Table 36. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021) & (US$ Million)

Table 37. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027) & (US$ Million)

Table 38. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)

Table 39. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)

Table 40. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)

Table 41. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)

Table 42. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021) & (US$ Million)

Table 43. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027) & (US$ Million)

Table 44. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)

Table 45. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)

Table 46. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)

Table 47. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)

Table 48. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2016-2021) & (US$ Million)

Table 49. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2022-2027) & (US$ Million)

Table 50. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)

Table 51. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)

Table 52. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)

Table 53. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)

Table 54. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021) & (US$ Million)

Table 55. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027) & (US$ Million)

Table 56. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2016-2021) (US$ Million)

Table 57. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2022-2027) & (US$ Million)

Table 58. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2016-2021) (US$ Million)

Table 59. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2022-2027) & (US$ Million)

Table 60. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2016-2021) & (US$ Million)

Table 61. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2022-2027) & (US$ Million)

Table 62. Abbott Company Details

Table 63. Abbott Business Overview

Table 64. Abbott Breast Cancer Diagnostic and Drug Technologies Product

Table 65. Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 66. Abbott Recent Development

Table 67. Roche Company Details

Table 68. Roche Business Overview

Table 69. Roche Breast Cancer Diagnostic and Drug Technologies Product

Table 70. Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 71. Roche Recent Development

Table 72. BioMerieux Company Details

Table 73. BioMerieux Business Overview

Table 74. BioMerieux Breast Cancer Diagnostic and Drug Technologies Product

Table 75. BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 76. BioMerieux Recent Development

Table 77. Becton Dickinson Company Details

Table 78. Becton Dickinson Business Overview

Table 79. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product

Table 80. Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 81. Becton Dickinson Recent Development

Table 82. GE Healthcare Company Details

Table 83. GE Healthcare Business Overview

Table 84. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product

Table 85. GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 86. GE Healthcare Recent Development

Table 87. Hologic Company Details

Table 88. Hologic Business Overview

Table 89. Hologic Breast Cancer Diagnostic and Drug Technologies Product

Table 90. Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 91. Hologic Recent Development

Table 92. Philips Company Details

Table 93. Philips Business Overview

Table 94. Philips Breast Cancer Diagnostic and Drug Technologies Product

Table 95. Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 96. Philips Recent Development

Table 97. PerkinElmer Company Details

Table 98. PerkinElmer Business Overview

Table 99. PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 100. PerkinElmer Recent Development

Table 101. Quest Diagnostics Company Details

Table 102. Quest Diagnostics Business Overview

Table 103. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product

Table 104. Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021) & (US$ Million)

Table 105. Quest Diagnostics Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Type: 2020 VS 2027

Figure 2. Mammography Features

Figure 3. Biopsy Features

Figure 4. Other Features

Figure 5. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application: 2020 VS 2027

Figure 6. Ductal Carcinoma of Breast Case Studies

Figure 7. Invasive Ductal Carcinoma Case Studies

Figure 8. Lobular Carcinoma Case Studies

Figure 9. Triple Negative Breast Cancer Case Studies

Figure 10. Breast Cancer Diagnostic and Drug Technologies Report Years Considered

Figure 11. Global Breast Cancer Diagnostic and Drug Technologies Market Size (US$ Million), Year-over-Year: 2016-2027

Figure 12. Global Breast Cancer Diagnostic and Drug Technologies Market Size (US$ Million), 2016 VS 2021 VS 2027

Figure 13. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions: 2020 VS 2027

Figure 14. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Regions (2022-2027)

Figure 15. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Players in 2020

Figure 16. Global Top Breast Cancer Diagnostic and Drug Technologies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2020

Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue in 2020

Figure 18. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2016-2021)

Figure 19. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2022-2027)

Figure 20. North America Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 21. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)

Figure 22. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)

Figure 23. North America Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2016-2027)

Figure 24. United States Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 25. Canada Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 26. Europe Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 27. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)

Figure 28. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)

Figure 29. Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2016-2027)

Figure 30. Germany Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 31. France Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 32. U.K. Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 33. Italy Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 34. Russia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 35. Nordic Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 36. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 37. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)

Figure 38. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)

Figure 39. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Share by Region (2016-2027)

Figure 40. China Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 41. Japan Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 42. South Korea Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 43. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 44. India Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 45. Australia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 46. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 47. Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)

Figure 48. Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)

Figure 49. Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2016-2027)

Figure 50. Mexico Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 51. Brazil Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 52. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 53. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2016-2027)

Figure 54. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2016-2027)

Figure 55. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Share by Country (2016-2027)

Figure 56. Turkey Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 57. Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 58. UAE Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2016-2027) & (US$ Million)

Figure 59. Abbott Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 60. Roche Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 61. BioMerieux Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 62. Becton Dickinson Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 63. GE Healthcare Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 64. Hologic Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 65. Philips Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 66. PerkinElmer Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 67. Quest Diagnostics Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2016-2021)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2021-2027

Published Date: July 2021

Report Code: QYRE-Auto-0Y3110

Global Breast Cancer Diagnostic and Drug Technologies Market Size, Status and Forecast 2021-2027

FEATURED COMPANIES

Breast Cancer Diagnostic and Drug Technologies Market

By Type

By Application

By Region

By Companies

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions